These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7835264)
41. [Oxitocin trough umbilical vein to shorten the third stage of labor]. Martínez MM; López Farfán JA; Ramos Alvarez G; López Colombo A Ginecol Obstet Mex; 2006 Feb; 74(2):89-94. PubMed ID: 16637377 [TBL] [Abstract][Full Text] [Related]
42. Removing a retained placenta by oxytocin--a controlled study. Wilken-Jensen C; Strøm V; Nielsen MD; Rosenkilde-Gram B Am J Obstet Gynecol; 1989 Jul; 161(1):155-6. PubMed ID: 2665493 [TBL] [Abstract][Full Text] [Related]
43. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery. Sundaram S; Diaz JP; González-Quintero VH; Verma U Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084 [TBL] [Abstract][Full Text] [Related]
44. Management of retained placenta by umbilical vein injection. Carroli G Br J Obstet Gynaecol; 1991 Apr; 98(4):348-50. PubMed ID: 2031892 [No Abstract] [Full Text] [Related]
45. [Intra-umbilical administration of oxytocin in the treatment of retained placenta]. Hansen P; Jørgensen L; Dueholm M; Hansen S Ugeskr Laeger; 1987 Nov; 149(49):3318-9. PubMed ID: 3445374 [No Abstract] [Full Text] [Related]
46. Umbilical oxytocin injection for the treatment of retained placentas. Weeks AD Trop Doct; 2003 Jul; 33(3):162-3. PubMed ID: 12870604 [No Abstract] [Full Text] [Related]
47. The use of serial betaHCG to plan surgical evacuation of retained placenta in a case of placenta accreta. Kulkarni A; Draycott T J Matern Fetal Neonatal Med; 2005 Apr; 17(4):295-7. PubMed ID: 16147840 [TBL] [Abstract][Full Text] [Related]
48. Continuous infraclavicular brachial plexus block: a modified technique to better secure catheter position in infants and children. Ponde VC Anesth Analg; 2008 Jan; 106(1):94-6, table of contents. PubMed ID: 18165560 [TBL] [Abstract][Full Text] [Related]
49. Comparison of subcutaneous infusion needles for transfusion-dependent thalassemia patients by the intrapersonal cross-over assessment model. Chan GC; Ng DM; Fong DY; Ha SY; Lau YL Am J Hematol; 2004 Aug; 76(4):398-404. PubMed ID: 15282678 [TBL] [Abstract][Full Text] [Related]
50. Vascular access. How to set up a drip and keep it going. Clutton-Brock TH Br J Hosp Med; 1984 Oct; 32(4):162, 164, 166-7. PubMed ID: 6487875 [TBL] [Abstract][Full Text] [Related]
51. Oxytetracycline residues in milk after intrauterine treatment of cows with retained fetal membranes. Dinsmore RP; Stevens RD; Cattell MB; Salman MD; Sundlof SF J Am Vet Med Assoc; 1996 Nov; 209(10):1753-5. PubMed ID: 8921036 [TBL] [Abstract][Full Text] [Related]
52. Effect of umbilical vein oxytocin injection on the third stage of labor: a randomized controlled study. Kovavisarach E; Rojsangruang S J Med Assoc Thai; 1998 Sep; 81(9):693-7. PubMed ID: 9737127 [TBL] [Abstract][Full Text] [Related]
53. A prospective randomized comparison of ultrasound and neurostimulation as needle end points for interscalene catheter placement. Fredrickson MJ; Ball CM; Dalgleish AJ; Stewart AW; Short TG Anesth Analg; 2009 May; 108(5):1695-700. PubMed ID: 19372356 [TBL] [Abstract][Full Text] [Related]
54. Chronic intravenous infusion in the rat: a nonsurgical approach. Rhodes ML; Patterson CE Lab Anim Sci; 1979 Feb; 29(1):82-4. PubMed ID: 439852 [TBL] [Abstract][Full Text] [Related]
55. Changing practice in the subcutaneous infusion of fluids to improve safety. Reynolds A Prof Nurse; 2004 Nov; 20(3):50-1. PubMed ID: 15552442 [TBL] [Abstract][Full Text] [Related]
56. Intervention rates for placental removal following induction abortion with misoprostol. Green J; Borgatta L; Sia M; Kapp N; Saia K; Carr-Ellis S; Vragovic O Contraception; 2007 Oct; 76(4):310-3. PubMed ID: 17900443 [TBL] [Abstract][Full Text] [Related]
57. The effect of oxytocin injection into the umbilical vein for the management of the retained placenta. Kristiansen FV; Frost L; Kaspersen P; Møller BR Am J Obstet Gynecol; 1987 Apr; 156(4):979-80. PubMed ID: 3555083 [TBL] [Abstract][Full Text] [Related]
58. Regarding Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol. 2007;86:48-54. van Stralen G; van Roosmalen J Acta Obstet Gynecol Scand; 2007; 86(6):764; author reply 765. PubMed ID: 17520415 [No Abstract] [Full Text] [Related]
59. Uterine artery embolization and hysteroscopic resection to treat retained placenta accreta: A case report. Greenberg JA; Miner JD; O'Horo SK J Minim Invasive Gynecol; 2006; 13(4):342-4. PubMed ID: 16825079 [TBL] [Abstract][Full Text] [Related]
60. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. van Beekhuizen HJ; de Groot AN; De Boo T; Burger D; Jansen N; Lotgering FK Am J Obstet Gynecol; 2006 Feb; 194(2):446-50. PubMed ID: 16458644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]